← Back
Data updated: Mar 29, 2026
ZHEJIANG JINGXIN
CardiovascularNeurology
Generics
ZHEJIANG JINGXIN is a generic drug manufacturer focused on Cardiovascular, Neurology.
2010
Since
3
Drugs
-
Trials
169
Approved (2yr)
Key Drugs
No active drugs
Top Drug Revenues Pro
Loading...
Revenue Over Time Pro
Loading...
Therapeutic Areas
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Cardiovascular 86%
1 drugs
Neurology 14%
0 drugs Phase 1: 1
Pipeline Forecast
Loading...
Loading...
Upcoming Trial Milestones Pro
Loading...
Patent Cliff Pro
Loading...
Loading...
Loading...
Active (2)
Discontinued (1)
Company Info
- First Approval
- 2010-12-14
- Latest
- 2023-07-26
- Applications
- 3